Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase

Journal of Inherited Metabolic Disease

Volumn 20, Issue 4, 1997, Pages 595-602

  Young, E ^a   Chatterton, C ^a   Vellodi, A ^a   Winchester, B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGLUCERASE; CHITINASE; PLACENTA ENZYME;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; HUMAN CELL;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HEXOSAMINIDASES; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0030796039     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005367328003     Document Type: Article

References (14)

1. Barton NW, Brady RO, Dambrosia JM, et al (1991) Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 324: 1464-1470.
2. Beutler E, Grabowski GA (1995) Gaucher disease. In Scriver CR, Beaudet WS, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 2641-2670.
3. Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JMFG (1995) Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 270: 26252-26256.
4. Den Tandt WR, Van Hoof F (1996) Marked increase in methylumbelliferyl-tetra-N-acetyltetraoside hydrolase activity in plasma from Gaucher disease patients. J Inher Metab Dis 19: 344-350
5. Grabowski GA, Barton NW, Pastores G, et al (1995) Enzyme therapy in Type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med 122: 33-39.
6. Guo Y, He W, Boer Am, et al (1995) Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inher Metab Dis 18: 717-722.
7. Hobbs JR, Hugh-Jones K, Shaw PJ, Lindsay I, Hancock M (1987) Beneficial effects of pretransplant splenectomy on displacement bone marrow transplantation for Gaucher's disease. Lancet i: 1111-1115.
8. Hollak CEM, van Weely S, van Oers MHJ, Aerts JMFG (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93: 1288-1292.
9. Hollak CEM, Aerts JMFG, Goudsmit R, et al (1995) Individualised low-dose alglucerase therapy for Type 1 Gaucher's disease. Lancet 345: 1474-1478.
10. Pastores GM, Sibille AR, Grabowski GA (1993) Enzyme therapy in Gaucher disease Type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood 82: 408-416.
11. Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JMFG (1995) Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem 270: 2198-2202.
12. Ringden O, Groth CG, Erikson A, Granqvist S, Mansson JE, Sparrelid E (1995) Ten years experience of bone marrow transplantation for Gaucher disease. Transplantation 59: 864-870.
13. Yang Y, Hamaguchi K (1980) Hydrolysis of 4-methylumbelliferyl-N-acetyl chitotetraoside catalyzed by lysozyme. J Biochem 88: 829-836.
14. Zimran A, Elstein D, Kannai R, Zevin S, Hadas-Halpern I, Levy-Lahad E (1994) Low-dose enzyme replacement therapy for Gaucher disease: effects of age, sex, genotype and clinical features on response to treatment. Am J Med 97: 3-13.